Bio Farma aims to make IndoVac as COVID-19 Multi-strain Vaccine


President Director of state-owned pharmaceutical company PT Bio Farma Honesti Basyir stated that his company is aiming to make its COVID-19 vaccine, IndoVac, a multi-strain vaccine after the COVID-19 pandemic subsides. Basyir noted that despite the COVID-19 pandemic having subsided, the IndoVac vaccine is projected to become part of the national health system in Indonesia.


January 25 2023, Tempo

 
To Top